id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-288038-jdinf8od	Thindwa, Deus	Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality	2020-06-19		.txt	text/plain	2601	119	40	Vaccinating older adults at elevated risk of severe COVID-19 disease against vaccine preventable diseases may therefore not only help to reduce the strain on the healthcare system from those diseases during a pandemic, but also alleviate some of the potential COVID-19 mortality due to co-infecting pathogens [8] . Similarly, maintaining high vaccine coverage of existing PCV and live attenuated influenza vaccine programmes in children reduces the associated disease burden in older adults through herd effects, and will further enhance benefits for limiting COVID-19 risks. In summary, where already in routine use among older adults and/or adults at-risk, maintaining both seasonal influenza and PPV23 at high coverage have the potential to not only reduce the burden of the targeted diseases but also prevent a proportion of COVID-19 morbidity and mortality, if they can be delivered while minimising the risk for SARS-CoV-2 transmission.	./cache/cord-288038-jdinf8od.txt	./txt/cord-288038-jdinf8od.txt